A new study has shown that the use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia (TGN) may produce long-term pain relief. TGN is a condition involving sudden episodes of severe facial pain that significantly reduces the quality of life in those affected. When medication fails to control the pain, some patients turn...
Big data enables algorithm that predicts risk of developing deadly diseases
A new kind of genome analysis has been developed that is claimed to be able to combine a large volume of different genetic variants into a single polygenic risk score that can determine how likely a person is to develop a number of common diseases, including coronary artery disease and inflammatory bowel disease. It’s hoped...
Innovative triple pill significantly lowers blood pressure, study finds
GEORGE INSTITUTE FOR GLOBAL HEALTH A new low dose three in one pill to treat hypertension could transform the way high blood pressure is treated around the world. A trial led by The George Institute for Global Health revealed that most patients – 70 percent – reached blood pressure targets with the ‘Triple Pill’, compared...
Online solution for OCD treatment
Almost 1 in 30 Australians experience Obsessive-Compulsive Disorder (OCD) at some stage in their life. Clinical psychologist, Flinders University Professor Michael Kyrios, is vice-president and executive dean of the College of Education, Psychology and Social Work. Credit: Flinders University OCD, previously recognized by the World Health Organisation as a top 10 (#9) cause of disability in...
Actisound Intense Therapeutic Ultrasound Device Cleared in Europe
Guided Therapy Systems, based in Mesa, Arizona, landed EU CE mark approval (via Ardent Sound Inc., Guided’s partner, and manufacturer) for the Actisound Intense Therapeutic Ultrasound device. It’s intended to help recover from a variety of injuries and chronic pain resulting from internal soft tissues. The device is used to create small ablations within the tendons,...
Shift Labs Announces Partnership with Option Care Enterprises for National Use of DripAssist
DripAssist by Shift Labs is an infusion rate monitor that offers a significant improvement in portability, efficiency, durability and ease of use over traditional infusion monitors. The last time Medgadget reported on Shift Labs, the company had just received their CE mark for DripAssist. The device is also FDA approved. Now, Shift Labs is announcing a partnership with Option Care Enterprises, one of...
Suicidal Vet Calls MDMA Treatment ‘a Miracle’
He suffered from post-traumatic stress disorder after the Iraq War. Thanks to MDMA, Jonathan Lubecky finally feels like he’s recovering. Jonathan Lubecky is a 41-year-old veteran who, until a few years ago, suffered from a severe form of Post-Traumatic Stress Disorder (PTSD). Lubecky attempted suicide five times after he was discharged from the Army in...
New aid to help identify and manage patients with diabetes at increased risk of fracture
Fragility fractures are a serious yet neglected complication of both type 1 and type 2 diabetes, with an increased risk of fragility fractures in people with diabetes extending across the lifespan. Fracture risk management in patients with diabetes. Credit: International Osteoporosis Foundation This is a concern as, globally, the prevalence of diabetes in adults is...
MSU scientists unraveled the influence of aging on kidneys regeneration ability
LOMONOSOV MOSCOW STATE UNIVERSITY Autophagy is a process of destruction and processing of damaged cell components by the cells themselves. It is used by a cell to clean itself of excessive organelles and sometimes for self-execution. This adaptive mechanism supports a healthy phenotype on the cellular level. Autophagy is activated in certain cases of acute...
Artificial intelligence platform screens for acute neurological illnesses
An artificial intelligence platform designed to identify a broad range of acute neurological illnesses, such as stroke, hemorrhage, and hydrocephalus, was shown to identify disease in CT scans in 1.2 seconds, faster than human diagnosis, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published today in the journal...